Yi Zhang
Corporate Officer/Principal chez The University of North Carolina at Charlotte
Profil
Yi Zhang is the founder of Epizyme, Inc. which was founded in 2007.
Currently, Dr. Zhang is a Professor at The University of North Carolina at Charlotte.
Dr. Zhang has a doctorate degree from Florida State University and undergraduate and graduate degrees from China Agricultural University.
Postes actifs de Yi Zhang
| Sociétés | Poste | Début |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
Anciens postes connus de Yi Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Fondateur | - |
Formation de Yi Zhang
| China Agricultural University | Graduate Degree |
| Florida State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |